HealthLynked (HLYK) Net Income towards Common Stockholders (2016 - 2025)

HealthLynked (HLYK) has disclosed Net Income towards Common Stockholders for 10 consecutive years, with -$529586.0 as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 68.31% to -$529586.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.8 million, a 46.06% increase, with the full-year FY2024 number at -$6.1 million, down 505.76% from a year prior.
  • Net Income towards Common Stockholders was -$529586.0 for Q3 2025 at HealthLynked, down from -$435385.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 million in Q1 2023 to a low of -$7.9 million in Q1 2021.
  • A 5-year average of -$1.5 million and a median of -$1.2 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 1263.6% in 2021, then surged 215.55% in 2023.
  • HealthLynked's Net Income towards Common Stockholders stood at -$1.8 million in 2021, then tumbled by 141.85% to -$4.4 million in 2022, then surged by 70.53% to -$1.3 million in 2023, then rose by 4.32% to -$1.2 million in 2024, then skyrocketed by 56.95% to -$529586.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Net Income towards Common Stockholders are -$529586.0 (Q3 2025), -$435385.0 (Q2 2025), and -$617389.0 (Q1 2025).